Dyadic International Inc

NASDAQ:DYAI USA Biotechnology
Market Cap
$28.23 Million
Market Cap Rank
#25257 Global
#8634 in USA
Share Price
$0.78
Change (1 day)
-2.76%
52-Week Range
$0.75 - $1.41
All Time High
$10.26
About

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally. It utilizes the C1 platform in pharmaceutical applications, including the development and production of pharmaceutical products. The company offers Dapibus, a protein production platform that enable the rapid development and la… Read more

Dyadic International Inc (DYAI) - Total Liabilities

Latest total liabilities as of September 2025: $9.07 Million USD

Based on the latest financial reports, Dyadic International Inc (DYAI) has total liabilities worth $9.07 Million USD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Dyadic International Inc - Total Liabilities Trend (2003–2024)

This chart illustrates how Dyadic International Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Dyadic International Inc Competitors by Total Liabilities

The table below lists competitors of Dyadic International Inc ranked by their total liabilities.

Liability Composition Analysis (2003–2024)

This chart breaks down Dyadic International Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.85 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 3.48 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.78 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Dyadic International Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Dyadic International Inc (2003–2024)

The table below shows the annual total liabilities of Dyadic International Inc from 2003 to 2024.

Year Total Liabilities Change
2024-12-31 $7.46 Million +218.71%
2023-12-31 $2.34 Million -10.84%
2022-12-31 $2.63 Million -9.75%
2021-12-31 $2.91 Million +78.90%
2020-12-31 $1.63 Million +2.38%
2019-12-31 $1.59 Million +86.91%
2018-12-31 $849.64K +10.50%
2017-12-31 $768.89K -23.89%
2016-12-31 $1.01 Million -64.84%
2015-12-31 $2.87 Million -73.40%
2014-12-31 $10.80 Million -12.71%
2013-12-31 $12.37 Million +11.52%
2012-12-31 $11.09 Million -0.05%
2011-12-31 $11.10 Million +42.49%
2010-12-31 $7.79 Million +5.27%
2009-12-31 $7.40 Million -17.50%
2008-12-31 $8.97 Million -28.75%
2007-12-31 $12.59 Million -25.71%
2006-12-31 $16.95 Million +102.32%
2005-12-31 $8.38 Million +2.73%
2004-12-31 $8.15 Million +8903.15%
2003-12-31 $90.57K --